DDL Diagnostic Laboratory
Provider of specialty laboratory services and global central laboratory operations supporting preclinical through post-market clinical research. Offers custom assay development, bioanalytical PK/PD and immunogenicity testing, high-parameter flow cytometry, genomics/NGS, anatomic pathology (IHC/ISH/multiplex), spatial omics, bioinformatics pipelines, biobanking, and tailored logistics to support multinational clinical trials.
Industries
Nr. of Employees
medium (51-250)
DDL Diagnostic Laboratory
Products
Validated multiplex IHC panel catalog (HISTOPROFILE panels)
Pre‑validated multiplex immunohistochemistry panels for specific indications and custom multiplex panel development and validation for tissue phenotyping and spatial analysis.
Validated multiplex IHC panel catalog (HISTOPROFILE panels)
Pre‑validated multiplex immunohistochemistry panels for specific indications and custom multiplex panel development and validation for tissue phenotyping and spatial analysis.
Services
Custom panel design, validation, standardized instrument settings, sample processing and centralized analysis for clinical trials.
DNA/RNA extraction, targeted NGS panels, whole exome/genome sequencing, TCR/BCR repertoire sequencing, liquid biopsy NGS and related genomic analyses.
IHC, multiplex IHC/IF, ISH/RNAscope, imaging mass cytometry, digital imaging and image analysis, and biobank access for assay validation and biomarker studies.
Development, validation and routine analysis of PK, ADA and NAb assays across biologics and biosimilars using immunoassays, cell‑based assays and molecular platforms under GxP/CAP/CLIA frameworks.
GxP and FDA‑compliant pipelines for NGS and virology, cloud implementation for scalability, custom pipeline development and CDISC‑compatible data outputs.
Global sample management including kit distribution, satellite labs, specialized cold chain transport and 24/7 logistics support for multinational trials.
Custom panel design, validation, standardized instrument settings, sample processing and centralized analysis for clinical trials.
DNA/RNA extraction, targeted NGS panels, whole exome/genome sequencing, TCR/BCR repertoire sequencing, liquid biopsy NGS and related genomic analyses.
IHC, multiplex IHC/IF, ISH/RNAscope, imaging mass cytometry, digital imaging and image analysis, and biobank access for assay validation and biomarker studies.
Development, validation and routine analysis of PK, ADA and NAb assays across biologics and biosimilars using immunoassays, cell‑based assays and molecular platforms under GxP/CAP/CLIA frameworks.
GxP and FDA‑compliant pipelines for NGS and virology, cloud implementation for scalability, custom pipeline development and CDISC‑compatible data outputs.
Global sample management including kit distribution, satellite labs, specialized cold chain transport and 24/7 logistics support for multinational trials.
Expertise Areas
- Clinical trial central laboratory services
- Custom assay development and validation
- Flow cytometry and immunophenotyping
- Genomics and next‑generation sequencing
Key Technologies
- Next‑generation sequencing (NGS)
- Droplet digital PCR (ddPCR)
- qPCR / RT‑qPCR
- Spectral high‑parameter flow cytometry
News & Updates
Reported metrics: >300 studies ongoing, 5,209 sites, operations in 55 countries.
Cerba HealthCare group received EcoVadis 'Committed' sustainability medal in 2025.
Reported metrics: >300 studies ongoing, 5,209 sites, operations in 55 countries.
Cerba HealthCare group received EcoVadis 'Committed' sustainability medal in 2025.